Filtros : "European Journal of Clinical Pharmacology" Limpar

Filtros



Refine with date range


  • Source: European Journal of Clinical Pharmacology. Unidade: FMRP

    Subjects: POLIMORFISMO, ÓXIDO NÍTRICO, CÉLULAS SANGUÍNEAS, GENÓTIPOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      NAGASSAKI, S. et al. eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity. European Journal of Clinical Pharmacology, v. 65, n. 4, p. 385-392, 2009Tradução . . Disponível em: https://doi.org/10.1007/s00228-008-0602-7. Acesso em: 19 abr. 2024.
    • APA

      Nagassaki, S., Herculano, R. D., Graeff, C. F. de O., & Tanus-Santos, J. E. (2009). eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity. European Journal of Clinical Pharmacology, 65( 4), 385-392. doi:10.1007/s00228-008-0602-7
    • NLM

      Nagassaki S, Herculano RD, Graeff CF de O, Tanus-Santos JE. eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity [Internet]. European Journal of Clinical Pharmacology. 2009 ;65( 4): 385-392.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/s00228-008-0602-7
    • Vancouver

      Nagassaki S, Herculano RD, Graeff CF de O, Tanus-Santos JE. eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity [Internet]. European Journal of Clinical Pharmacology. 2009 ;65( 4): 385-392.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/s00228-008-0602-7
  • Source: European Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP

    Subjects: GASTROENTEROLOGIA, FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ROCHA, Adriana et al. Investigation of the in vivo activity of CYP3A in Brazilian volunteers: comparison of midazolam and omeprazole as drug markers. European Journal of Clinical Pharmacology, v. 64, n. 9, p. 901-906, 2008Tradução . . Disponível em: https://doi.org/10.1007/s00228-008-0510-x. Acesso em: 19 abr. 2024.
    • APA

      Rocha, A., Coelho, E. B., Moussa, S. A. P., & Lanchote, V. L. (2008). Investigation of the in vivo activity of CYP3A in Brazilian volunteers: comparison of midazolam and omeprazole as drug markers. European Journal of Clinical Pharmacology, 64( 9), 901-906. doi:10.1007/s00228-008-0510-x
    • NLM

      Rocha A, Coelho EB, Moussa SAP, Lanchote VL. Investigation of the in vivo activity of CYP3A in Brazilian volunteers: comparison of midazolam and omeprazole as drug markers [Internet]. European Journal of Clinical Pharmacology. 2008 ; 64( 9): 901-906.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/s00228-008-0510-x
    • Vancouver

      Rocha A, Coelho EB, Moussa SAP, Lanchote VL. Investigation of the in vivo activity of CYP3A in Brazilian volunteers: comparison of midazolam and omeprazole as drug markers [Internet]. European Journal of Clinical Pharmacology. 2008 ; 64( 9): 901-906.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/s00228-008-0510-x
  • Source: European Journal of Clinical Pharmacology. Unidades: FM, FMRP

    Subjects: DOENÇAS HEMATOLÓGICAS (EPIDEMIOLOGIA), FATORES DE RISCO, GRANULÓCITOS (PATOLOGIA), AMÉRICA LATINA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      HAMERSCHLAK, Nelson et al. Incidence and risk factors for agranulocytosis in Latin American countries-the Latin Study. European Journal of Clinical Pharmacology, v. 64, n. 9, p. 921-929, 2008Tradução . . Disponível em: https://doi.org/10.1007/s00228-008-0513-7. Acesso em: 19 abr. 2024.
    • APA

      Hamerschlak, N., Maluf, E., Cavalcanti, A. B., Avezun Júnior, Á., Eluf-Neto, J., Falcão, R. P., et al. (2008). Incidence and risk factors for agranulocytosis in Latin American countries-the Latin Study. European Journal of Clinical Pharmacology, 64( 9), 921-929. doi:10.1007/s00228-008-0513-7
    • NLM

      Hamerschlak N, Maluf E, Cavalcanti AB, Avezun Júnior Á, Eluf-Neto J, Falcão RP, Lorand-Metze IG, Goldenberg D, Santana CL, Rodrigues D de OW, Passos LN da M, Coelho EO de M, Pintão MCT, Souza HM de, Borbolla JR, Pasquini R. Incidence and risk factors for agranulocytosis in Latin American countries-the Latin Study [Internet]. European Journal of Clinical Pharmacology. 2008 ; 64( 9): 921-929.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/s00228-008-0513-7
    • Vancouver

      Hamerschlak N, Maluf E, Cavalcanti AB, Avezun Júnior Á, Eluf-Neto J, Falcão RP, Lorand-Metze IG, Goldenberg D, Santana CL, Rodrigues D de OW, Passos LN da M, Coelho EO de M, Pintão MCT, Souza HM de, Borbolla JR, Pasquini R. Incidence and risk factors for agranulocytosis in Latin American countries-the Latin Study [Internet]. European Journal of Clinical Pharmacology. 2008 ; 64( 9): 921-929.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/s00228-008-0513-7
  • Source: European Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP

    Assunto: ANESTESIA OBSTÉTRICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DUARTE, Luciana de Barros et al. Placental transfer of bupivacaine enantiomers in normal pregnant women receiving epidural anesthesia for cesarean section. European Journal of Clinical Pharmacology, v. 63, n. 5, p. 523-526, 2007Tradução . . Disponível em: https://doi.org/10.1007/s00228-007-0275-7. Acesso em: 19 abr. 2024.
    • APA

      Duarte, L. de B., Moisés, E. C. D., Cavalli, R. C., Lanchote, V. L., Duarte, G., & Cunha, S. P. da. (2007). Placental transfer of bupivacaine enantiomers in normal pregnant women receiving epidural anesthesia for cesarean section. European Journal of Clinical Pharmacology, 63( 5), 523-526. doi:10.1007/s00228-007-0275-7
    • NLM

      Duarte L de B, Moisés ECD, Cavalli RC, Lanchote VL, Duarte G, Cunha SP da. Placental transfer of bupivacaine enantiomers in normal pregnant women receiving epidural anesthesia for cesarean section [Internet]. European Journal of Clinical Pharmacology. 2007 ; 63( 5): 523-526.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/s00228-007-0275-7
    • Vancouver

      Duarte L de B, Moisés ECD, Cavalli RC, Lanchote VL, Duarte G, Cunha SP da. Placental transfer of bupivacaine enantiomers in normal pregnant women receiving epidural anesthesia for cesarean section [Internet]. European Journal of Clinical Pharmacology. 2007 ; 63( 5): 523-526.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/s00228-007-0275-7
  • Source: European Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP

    Subjects: FARMACOCINÉTICA, ANESTESIA OBSTÉTRICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MOISÉS, Elaine Christine Dantas et al. Pharmacokinetics and transplacental distribution of fentanyl in epidural anesthesia for normal pregnant women. European Journal of Clinical Pharmacology, v. 61, p. 517-522, 2005Tradução . . Disponível em: https://doi.org/10.1007/s00228-005-0967-9. Acesso em: 19 abr. 2024.
    • APA

      Moisés, E. C. D., Duarte, L. de B., Cavalli, R. de C., Lanchote, V. L., Duarte, G., & Cunha, S. P. da. (2005). Pharmacokinetics and transplacental distribution of fentanyl in epidural anesthesia for normal pregnant women. European Journal of Clinical Pharmacology, 61, 517-522. doi:10.1007/s00228-005-0967-9
    • NLM

      Moisés ECD, Duarte L de B, Cavalli R de C, Lanchote VL, Duarte G, Cunha SP da. Pharmacokinetics and transplacental distribution of fentanyl in epidural anesthesia for normal pregnant women [Internet]. European Journal of Clinical Pharmacology. 2005 ; 61 517-522.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/s00228-005-0967-9
    • Vancouver

      Moisés ECD, Duarte L de B, Cavalli R de C, Lanchote VL, Duarte G, Cunha SP da. Pharmacokinetics and transplacental distribution of fentanyl in epidural anesthesia for normal pregnant women [Internet]. European Journal of Clinical Pharmacology. 2005 ; 61 517-522.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/s00228-005-0967-9
  • Source: European Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP

    Subjects: ANALGESIA, OBSTETRÍCIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CAVALLI, Ricardo de Carvalho et al. Pharmacokinetics and transplacental transfer of lidocaine and its metabolite for perineal analgesic assistance to pregnant women. European Journal of Clinical Pharmacology, v. 60, p. 569-574, 2004Tradução . . Disponível em: https://doi.org/10.1007/s00228-004-0798-0. Acesso em: 19 abr. 2024.
    • APA

      Cavalli, R. de C., Lanchote, V. L., Duarte, G., Dantas, E. C. M., Prado, M. F. M. do, Duarte, L. de B., & Cunha, S. P. da. (2004). Pharmacokinetics and transplacental transfer of lidocaine and its metabolite for perineal analgesic assistance to pregnant women. European Journal of Clinical Pharmacology, 60, 569-574. doi:10.1007/s00228-004-0798-0
    • NLM

      Cavalli R de C, Lanchote VL, Duarte G, Dantas ECM, Prado MFM do, Duarte L de B, Cunha SP da. Pharmacokinetics and transplacental transfer of lidocaine and its metabolite for perineal analgesic assistance to pregnant women [Internet]. European Journal of Clinical Pharmacology. 2004 ; 60 569-574.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/s00228-004-0798-0
    • Vancouver

      Cavalli R de C, Lanchote VL, Duarte G, Dantas ECM, Prado MFM do, Duarte L de B, Cunha SP da. Pharmacokinetics and transplacental transfer of lidocaine and its metabolite for perineal analgesic assistance to pregnant women [Internet]. European Journal of Clinical Pharmacology. 2004 ; 60 569-574.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/s00228-004-0798-0
  • Source: European Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP

    Assunto: FARMACOLOGIA CLÍNICA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MARQUES, Maria Paula et al. Dynamic and kinetic disposition of nisoldipine enantiomers in hypertensive patients presenting with type-2 diabetes mellitus. European Journal of Clinical Pharmacology, v. 58, n. 9, p. 607-614, 2002Tradução . . Disponível em: https://doi.org/10.1007/s00228-002-0528-4. Acesso em: 19 abr. 2024.
    • APA

      Marques, M. P., Coelho, E. B., Santos, N. A. G., Geleilete, T. J. M., & Lanchote, V. L. (2002). Dynamic and kinetic disposition of nisoldipine enantiomers in hypertensive patients presenting with type-2 diabetes mellitus. European Journal of Clinical Pharmacology, 58( 9), 607-614. doi:10.1007/s00228-002-0528-4
    • NLM

      Marques MP, Coelho EB, Santos NAG, Geleilete TJM, Lanchote VL. Dynamic and kinetic disposition of nisoldipine enantiomers in hypertensive patients presenting with type-2 diabetes mellitus [Internet]. European Journal of Clinical Pharmacology. 2002 ; 58( 9): 607-614.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/s00228-002-0528-4
    • Vancouver

      Marques MP, Coelho EB, Santos NAG, Geleilete TJM, Lanchote VL. Dynamic and kinetic disposition of nisoldipine enantiomers in hypertensive patients presenting with type-2 diabetes mellitus [Internet]. European Journal of Clinical Pharmacology. 2002 ; 58( 9): 607-614.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/s00228-002-0528-4
  • Source: European Journal of Clinical Pharmacology. Unidade: FCF

    Subjects: FARMACOLOGIA, FARMACOCINÉTICA, BIODISPONIBILIDADE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DELLA PASCHOA, O E et al. Prolongation of the pq interval as a measure of therapeutic inequivalence between two formulations of diltiazem. European Journal of Clinical Pharmacology, v. 48, n. 1 , p. 45-9, 1995Tradução . . Disponível em: https://doi.org/10.1007/bf00202171. Acesso em: 19 abr. 2024.
    • APA

      Della Paschoa, O. E., Luckow, V., Trenk, D., Jahnchen, E., & Santos, S. R. C. J. (1995). Prolongation of the pq interval as a measure of therapeutic inequivalence between two formulations of diltiazem. European Journal of Clinical Pharmacology, 48( 1 ), 45-9. doi:10.1007/bf00202171
    • NLM

      Della Paschoa OE, Luckow V, Trenk D, Jahnchen E, Santos SRCJ. Prolongation of the pq interval as a measure of therapeutic inequivalence between two formulations of diltiazem [Internet]. European Journal of Clinical Pharmacology. 1995 ;48( 1 ): 45-9.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/bf00202171
    • Vancouver

      Della Paschoa OE, Luckow V, Trenk D, Jahnchen E, Santos SRCJ. Prolongation of the pq interval as a measure of therapeutic inequivalence between two formulations of diltiazem [Internet]. European Journal of Clinical Pharmacology. 1995 ;48( 1 ): 45-9.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/bf00202171
  • Source: European Journal of Clinical Pharmacology. Unidade: FMRP

    Assunto: FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DREWE, J et al. Differential effect of food on kinetics of bromocriptine in a modified release capsule and a conventional formulation. European Journal of Clinical Pharmacology, v. 35, n. 5 , p. 535-41, 1988Tradução . . Disponível em: https://doi.org/10.1007/bf00558250. Acesso em: 19 abr. 2024.
    • APA

      Drewe, J., Mazzer, N., Abish, E., Krummen, K., & Keck, M. (1988). Differential effect of food on kinetics of bromocriptine in a modified release capsule and a conventional formulation. European Journal of Clinical Pharmacology, 35( 5 ), 535-41. doi:10.1007/bf00558250
    • NLM

      Drewe J, Mazzer N, Abish E, Krummen K, Keck M. Differential effect of food on kinetics of bromocriptine in a modified release capsule and a conventional formulation [Internet]. European Journal of Clinical Pharmacology. 1988 ;35( 5 ): 535-41.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/bf00558250
    • Vancouver

      Drewe J, Mazzer N, Abish E, Krummen K, Keck M. Differential effect of food on kinetics of bromocriptine in a modified release capsule and a conventional formulation [Internet]. European Journal of Clinical Pharmacology. 1988 ;35( 5 ): 535-41.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1007/bf00558250

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024